|
Orphazyme A
ORPH's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Orphazyme A growth rates, revenue grew
in IV. Quarter 2021 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 29.91 %
Orphazyme A net loss deacreased by in IV. Quarter 2021 year on year, Orphazyme A net loss increased by -1.06 % in IV. Quarter 2021 year on year,
• More on ORPH's Growth
|
|
Orphazyme A reported net loss of -627 millions in the past twelve months.
Company is currently trading with Price to Cash flow multiple of 0.25 in trailing twelve-month period. |
| | | |